USX:GRPH - Graphite Bio, Inc. Common Stock Graphite Bio, Inc. Common Stoc
Sector: Health Care, Industry: Biotechnology
Add to Watchlist
   
Add Alert 


Yahoo Finance

USD 21.48    -0.170 (-0.79%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

28 Jul 2021


Loading...
Loading...
Loading...

General

Headquarters: US

Description

Graphite Bio Inc is a clinical-stage gene-editing company harnessing gene integration to develop a new class of therapies to cure serious and life-threatening diseases. Its gene-editing platform allows to precisely correct mutations, replace entire disease-causing genes with normal genes, or insert new genes into predetermined, safe locations.